Mangoceuticals, Inc. MGRX Stock Forecast
AI-powered price prediction and analysis for Mangoceuticals, Inc. · Total · absolute moveSwitch to Alpha
See MGRX's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Mangoceuticals, Inc.
Mangoceuticals, Inc. (MGRX) operates within the Industrial Applications and Services sector, specifically in the Services-Misc Health & Allied Services, NEC industry.
Latest News
- Mangoceuticals Secures $492,750 Through Registered Direct Offering of Common Stock and Warrants
- Mangoceuticals (MGRX) shares fall 12% after hours: Here's why
- Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
- Sign up free to read all 10 articles →
Where MGRX sits on the market map
Services-Misc Health & Allied Services, NEC Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| MGRX Mangoceuticals, Inc. | ▶ | $8M | – |
| DVA Davita Inc. | ▶ | $11.62B | 13.7x |
| FMS Fresenius Medical Care Ag | ▼ | $5.89B | – |
| SHC Sotera Health Co | ▶ | $5.20B | 31.8x |
| PGNY Progyny, Inc. | ▶ | $2.10B | 26.7x |
| AGL Agilon Health, Inc. | ▲ | $1.44B | – |
| VMD Viemed Healthcare, Inc. | ▶ | $366M | 25.3x |
| PARK Park Dental Partners, Inc. | ▶ | $93M | – |
| MRAI Marpai, Inc. | ▲ | $86M | – |
| CCEL Cryo Cell International Inc | ▶ | $35M | – |
| PFHO Pacific Health Care Organization … | ▶ | $12M | 12.2x |
| BRTX Biorestorative Therapies, Inc. | ▼ | N/A | – |
| NIVF Newgenivf Group Ltd | ▼ | N/A | – |
FAQ
Is Mangoceuticals, Inc. a good stock to buy?
Our AI analyzes Mangoceuticals, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Mangoceuticals, Inc. predictions?
A per-ticker accuracy statistic for MGRX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Mangoceuticals, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Mangoceuticals, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.